Skip to main content
TipRanks
Go Ultimate75% OFF

Sun Life Financial (LIE) Q3 2026 Earnings Report

3 Followers

DE:LIE Q3 2026 EPS Results

Actual EPS
EUR 1.30
Consensus EPS
EUR 1.28
Beat/Miss
Beat by +EUR 0.03
One Year Ago EPS
EUR 1.18

DE:LIE Q3 2026 Revenue Results

Actual Revenue
EUR 5.72B
Expected Revenue
EUR 893.19M
Beat/Miss
Beat by +EUR 4.83B
YoY Revenue Growth
-27.50%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/04/2026
Time
After Close
Conference Call
Wednesday, November 4, 2026
DE:LIE Upcoming Earnings

Sun Life Financial's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:LIE Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 04, 2026|% Change Since:-8.20%|
Earnings Call Sentiment|Positive

The call was broadly positive, supported by 10% underlying EPS growth, 19% ROE, strong capital, shareholder returns, broad-based earnings growth and strong performance in Canada, Asia, GreenOak and U.S. medical stop-loss. The company also highlighted progress in digital, AI, infrastructure, wealth and asset management initiatives. Offsetting issues included MFS outflows, elevated U.S. disability claims, muted U.S. dental earnings, reported earnings impacts from markets and integration costs, and lower Asia new business CSM. Highlights significantly outweighed the lowlights, while management acknowledged that several challenges would persist in the near term.

Company Guidance

Sun Life said underlying EPS growth remains in line with its objective of 10%, underlying ROE is within reach of its 20% target, and the dividend payout ratio remains within the target 40% to 50% range; it remains confident in GreenOak’s target of 35% plus FRE margin and expects the Wilton Re vehicle to grow to USD 10 billion over time, while GreenOak integration and restructuring costs are expected to continue in 2027. Management said it continues to feel very comfortable in generating double-digit earnings growth in Asia going forward, expects MFS’ current flow conditions to persist in the near term, and expects U.S. LTD claims to remain elevated in the near term, with repricing typically affecting about 1/3 of premium volume each year over a 2- to 3-year time frame. U.S. dental underlying net income is expected to remain muted, U.S. stop-loss remains a hard market and is expected to continue through the 1/1 cycle, and the 20% ROE objective remains a medium-term objective defined as 3 to 5 years.

  • Double-Digit Underlying EPS Growth and Strong ROEUnderlying net income was $1.146 billion, up 9% from the prior year, while underlying EPS was $2.05, up 10%. Underlying return on equity was 19%, within reach of the company's 20% medium-term target.
  • Strong Capital Position and Shareholder ReturnsThe LICAT ratio was 142%, described as industry-leading, despite declining 3 percentage points from the second quarter. The company returned $780 million to shareholders through dividends and share repurchases, including $246 million of share repurchases, and increased the quarterly dividend by $0.04 to $1 per common share. The dividend payout ratio was 47%, within the 40% to 50% target range.
  • Broad-Based Business Group Earnings GrowthUnderlying earnings increased across all four business groups. Canada underlying net income increased 6% to $422 million, Asia underlying net income increased 8% on a constant-currency basis to $227 million, and U.S. underlying net income increased 32% to USD 141 million.
  • Strong Canadian Wealth PerformanceCanada wealth assets under management and administration increased 11% to $284 billion, supported by strong rollover activity, mutual fund sales and equity market performance. Canada wealth fee income benefited from the growth in assets and scale efficiencies, with wealth business margin increasing 25%. Canada year-to-date expenses grew 2% while earnings grew 12%.
  • Growth in Insurance and Wealth SalesInsurance sales increased 12%, driven by continued growth in Asia and strong group benefit sales in Canada and the U.S. Canadian wealth sales increased 21%, Asia individual insurance sales increased 9% to $937 million, and U.S. medical stop-loss sales increased 62%.
  • Asia Sales Growth Across Multiple MarketsAsia individual insurance sales increased 9% to $937 million. Sales increased 6% in Hong Kong, 60% in Malaysia, 33% in India and 26% in Indonesia, supported by strong bancassurance performance. Asia year-to-date earnings were up 14% year-over-year, and management said it remained comfortable generating double-digit earnings growth going forward.
  • U.S. Medical Stop-Loss MomentumU.S. medical stop-loss performance benefited from a lower loss ratio compared with the prior year. Earnings in Health and Risk Solutions were up 45% year-over-year after adjusting for the Q3 2025 reserve change, with growth driven primarily by pricing actions, higher sales and persistency. Q3 2026 premiums were $879 million versus $679 million in Q3 2025, a 30% volume increase.
  • Strong U.S. Stop-Loss Pipeline and Risk SelectionManagement said the medical stop-loss business remained in a hard market, with a large pipeline for the 1/1/27 renewal cycle. The company said it felt good about its pricing position, differentiated capabilities and disciplined risk selection.
  • Commercial Dental Sales GrowthCommercial dental sales more than doubled during the quarter, reflecting the company's strategic focus on the higher-margin segment of the dental market.
  • GreenOak Earnings, Fundraising and Deployment GrowthGreenOak underlying earnings increased, supported by growing fee-earning assets, cost discipline and the Bell Partners contribution. GreenOak gross flows increased 8%, net flows were $4 billion, quarterly fundraising was $3.5 billion and gross deployments were $7.1 billion, up from both the prior year and the prior quarter.
  • GreenOak Integration and Margin Expansion PlanSun Life launched GreenOak as the new brand for SLC and began integrating five businesses under one platform. Management said the current high-20s FRE margin was not the intended ending margin and maintained a target of 35% or higher, supported by revenue and expense synergies, centralized institutional distribution and consolidated corporate and middle- and back-office functions.
  • Strategic Partnerships and Asset Management ScaleGreenOak entered a strategic partnership with Wilton Re to serve as lead asset manager for a reinsurance vehicle expected to grow to USD 10 billion over time. Sun Life also completed the Bell Partners acquisition and ranked in the top five globally for private real estate capital raised over the last five years in the PERE 100.
  • Canadian Infrastructure CommitmentSun Life committed $5 billion over five years to Canadian infrastructure, including $1.5 billion for equity investments. Management described the initiative as supporting economic growth while delivering attractive long-term returns.
  • MFS Product Growth and Cost DisciplineDespite industry-wide active-management outflows, MFS generated more than USD 650 million of ETF net flows, launched two new ETFs, recorded USD 300 million of fixed-income net inflows and continued to build growth areas including ETFs, fixed income, retail SMAs and blended research. Management said approximately two-thirds of MFS costs are directly variable and that expenses have been managed carefully.
  • Digital, AI and Client Experience ProgressSun Life continued investing in AI and digital capabilities, including machine learning for medical claims, AI-enabled claims reimbursement, enhanced claims automation in Indonesia that increased straight-through processing by 20%, and new AI tools for advisers across Asia. The company received two 2026 Global Insurance Innovation Awards in Canada. Digital client initiatives were associated with a 25% increase in group wealth lump-sum contributions and a 30% increase in health solutions.
  • New Client and Wealth OfferingsThe company launched Sun Life Private Wealth to combine global insurance, wealth and advisory capabilities for high-net-worth clients, introduced online counseling by Dialogue and refreshed its brand and tagline, 'Making life brighter.'
  • Expense Discipline Across the CompanyConsolidated other expenses were $459 million, down 5% year-over-year and also down quarter-over-quarter. Management said the reduction reflected broad-based expense discipline across Canada, investments and the U.S., with the restructuring program largely completed in the first quarter of 2026 and a portion of the savings expected to be sustainable.
  • Positive Canadian Disability ExperienceCanadian morbidity experience remained positive and within the normal range of expectations, although lower in the quarter. Management attributed the relative performance to disciplined pricing, operational management, technology investment, long-term disability focus and close client relationships.
  • Progress on Medium-Term ObjectivesManagement said underlying EPS growth was in line with its 10% objective, ROE was at 19% versus a 20% target, the dividend payout ratio remained within target and the company remained on a good trajectory toward its medium-term objectives.

DE:LIE Earnings History

DE:LIE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 09, 20272026 (Q4)1.31-1.25――
Nov 04, 20262026 (Q3)1.281.301.1810.22% (+0.12)
Aug 06, 20262026 (Q2)1.231.281.1412.85% (+0.15)
May 06, 20262026 (Q1)1.201.201.163.85% (+0.04)
Feb 11, 20262025 (Q4)1.191.251.0716.67% (+0.18)
Nov 05, 20252025 (Q3)1.161.181.125.68% (+0.06)
Aug 07, 20252025 (Q2)1.131.141.094.07% (+0.04)
May 08, 20252025 (Q1)1.081.160.9521.33% (+0.20)
Feb 12, 20252024 (Q4)1.131.071.070.00% (+0.00)
Nov 04, 20242024 (Q3)1.081.121.0110.69% (+0.11)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed